Status:
COMPLETED
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.
Lead Sponsor:
Institut Bergonié
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The hypothesis is that radiofrequency ablation combined or not with resection may allow a local control (the liver) in patients suffering from unresectable colorectal liver metastases. Patients may ha...
Eligibility Criteria
Inclusion
- Colorectal cancer Hepatic metastases unresectable by classical surgery Performance status \< 2
Exclusion
- \-
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00210106
Start Date
June 1 2003
End Date
May 1 2010
Last Update
May 18 2021
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Angers
Angers, France, 49000
2
Centre Saint Michel
Angoulême, France, 16000
3
CHU de Bordeaux
Bordeaux, France, 33076
4
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
Bordeaux, France, 33076